http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103096916-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103096916-B |
titleOfInvention | For the preparation of bG-CSF and variant thereof |
abstract | The invention provides the stable aqueous formulation comprising bG-CSF polypeptide or its variant, buffer substance and excipient, wherein said preparation is substantially free of polyoxyethylene (20) Span-20.Present invention also offers the method using the lyophilized form of described preparation or the method for powder type and prepare described preparation. |
priorityDate | 2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.